Skip to Primary Navigation

CVS pays over $18m to settle federal and California FCA allegations

CVS store sign post.
Photo: Brandon Bell/Getty Images

The settlement resolves claims from a former CVS pharmacist under federal FCA whistleblower provisions.

The US Department of Justice (DOJ) announced an $18.282m settlement with CVS Pharmacy Inc to resolve allegations that the latter violated the Federal False Claims Act (FCA) and the California False Claims Act. The DOJ alleges the pharmacy chain knowingly filed claims for reimbursement for prescription drugs to California’s Medi-Cal

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience